Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9XRT
|
||||
| Drug Name |
[(S)-1-(2,5-Dioxo-1-phenethyl-piperidin-4-ylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL100702
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H31N3O5
|
||||
| Canonical SMILES |
O=C(N[C@@H](Cc1ccccc1)C(=O)NC2CC(=O)N(CCc3ccccc3)CC2=O)OCc4ccccc4
|
||||
| InChI |
InChI=1S/C30H31N3O5/c34-27-20-33(17-16-22-10-4-1-5-11-22)28(35)19-25(27)31-29(36)26(18-23-12-6-2-7-13-23)32-30(37)38-21-24-14-8-3-9-15-24/h1-15,25-26H,16-21H2,(H,31,36)(H,32,37)/t25?,26-/m0/s1
|
||||
| InChIKey |
WWJXDXQVSFLZSC-AMVUTOCUSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.